Skip to main content
Log in

Correlation of p53 with the clinicopathologic features and prognosis of colorectal adenocarcinoma

  • Short Communication
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Immunohistochemical staining of p53 was performed using an anti-p53 mouse monoclonal antibody, Pab1801, on 67 colorectal adenocarcinoma specimens to determine the prognostic value of p53 in colorectal cancer patients. Of a total of 67 tumors examined, p53 was detected in 34, but the rate of positive staining for p53 did not correlate with the clinical stage of disease. In 59 patients undergoing curative resection of the tumor, there was no significant difference in the recurrence rate (P = 0.137) or the disease-free survival rate between 28 patients with p53 positive tumors and 31 with p53 negative tumors (P = 0.135).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Porter PL, Gown AM, Kramp SG, Coltrera M (1992) Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue. Am J Pathol 140:145–153

    Google Scholar 

  2. Purdie CA, O'Grady J, Piris J, Wyllie AH, Bird CC (1991) p53 expression in colorectal tumors. Am J Pathol 138:807–813

    Google Scholar 

  3. Scott N, Sagar P, Stewart J, Blair GE, Dixon MF, Quirke P (1991) p53 in colorectal cancer: Clinicopathological correlation and prognostic significance. Br J Cancer 63:317–319

    Google Scholar 

  4. Farmer MH (1978) TNM classification of malignant tumors, 3rd edn. International Union Against Cancer, Geneva

    Google Scholar 

  5. Finlay CA, Hinds PW, Levine AJ (1989) The p53 protooncogene can act as a suppressor of transformation. Cell 57:1083–1093

    Google Scholar 

  6. Rogel A, Popliker M, Webb CG, Oren M (1985) p53 cellular tumor antigen: Analysis of mRNA levels in normal adult tissues, embryos, and tumors. Mol Cell Biol 2851–2855

  7. Cattoretti G, Rilke F, Andreola S, D'Amato L, Delia D (1988) p53 expression in breast cancer. Int J Cancer 41:178–183

    Google Scholar 

  8. Iggo R, Gatter K, Bartek J, Lane D, Harris AL (1990) Increased expression of mutant form of p53 oncogene in primary lung cancer. Lancet 335:675–679

    Google Scholar 

  9. Seruca R, David L, Holm R, Nesland JM, Fangan BM, Castedo S, Sobinho-Simoes M, Børresen A-L (1992) p53 mutations in gastric carcinomas. Br J Cancer 65:708–710

    Google Scholar 

  10. Martin HM, Filipe MI, Morris RW, Lane DP, Silvestre F (1992) p53 expression and prognosis in gastric carcinoma. Int J Cancer 50:859–862

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Suzuki, H., Matsumoto, K., Koide, A. et al. Correlation of p53 with the clinicopathologic features and prognosis of colorectal adenocarcinoma. Surg Today 24, 85–87 (1994). https://doi.org/10.1007/BF01676893

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01676893

Key Words

Navigation